🇯🇵 Tafinlar in Japan

PMDA authorised Tafinlar on 28 March 2016

Marketing authorisation

PMDA — authorised 28 March 2016

  • Marketing authorisation holder: Novartis Pharma K.K.
  • Status: approved

Tafinlar in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Japan

Frequently asked questions

Is Tafinlar approved in Japan?

Yes. PMDA authorised it on 28 March 2016.

Who is the marketing authorisation holder for Tafinlar in Japan?

Novartis Pharma K.K. holds the Japanese marketing authorisation.